SOURCE: I-trax

February 28, 2008 16:24 ET

I-trax Announces 2007 Results

Fourth Quarter Revenue Increases 19.2%; Record Full Year Revenue of $143.2 million

CHADDS FORD, PA--(Marketwire - February 28, 2008) - I-trax, Inc. (AMEX: DMX), the leading provider of integrated health and productivity management, today reported financial results for the fourth quarter and year ended December 31, 2007.

Highlights

For the quarter ended December 31, 2007, I-trax reported record net revenue of $40.0 million and net income of $0.3 million. Net income applicable to common stockholders was $0.2 million, or $0.00 per diluted share. As of December 31, 2007, I-trax was providing services at 243 sites, a net increase of nine sites during the fourth quarter and 31 for the year.

Earnings before interest, taxes, depreciation, and amortization ("EBITDA") for the quarter ended December 31, 2007 were $1.7 million compared to adjusted EBITDA of $1.1 million in the prior year period. EBITDA for the quarter ended December 31, 2006 was adjusted $1.3 million for proceeds from discontinued operations.

On December 14, 2007, I-trax completed its acquisition of ProFitness Health Solutions, LLC, a provider of employer-sponsored wellness, fitness and occupational health services in 22 states for over 50 clients. The Company was advised on this acquisition by its mergers and acquisitions advisors, Bryant Park Capital, LLC. The purchase price for the acquisition was $8.3 million, subject to certain adjustments. To fund the acquisition, I-trax entered into a Ninth Amendment to its Credit Agreement with Bank of America, N.A., which increased the facility to $25.0 million. Operating results of ProFitness will be combined with the results of I-trax commencing January 1, 2008. Consequently, the accompanying statements of operations for the quarter and year ended December 31, 2007 do not include any results of operations from ProFitness.

Commenting on these results, Frank A. Martin, chairman, said, "We are extremely pleased with our fourth quarter and full year results from 2007. Not only did we achieve organic growth in revenues of approximately 15% year-over-year, we realized anticipated leverage on our investments -- as adjusted EBITDA grew at almost twice our revenue growth rate -- 28%. We believe with our acquisition of ProFitness we are poised to continue and accelerate our growth in 2008. With the addition of ProFitness's expertise in workplace wellness and fitness services, we offer a unique and robust slate of services to help our customers meet their employees' healthcare needs. The fourth quarter of 2007 is our fifth consecutive quarter of increasing revenue growth rate. Our fourth quarter net revenue of $40.0 million represents a new record and our full year revenue of $143.2 million is in line with guidance given last year. Sales opportunities continue to grow in number as well as dollar value, and we are excited about the cross-sell possibilities created by the acquisition of ProFitness. With our service offerings leveraged by the distinctive trusted on-site clinician relationship, we believe we will continue to help our clients provide exceptional workplace-based healthcare.

"Our fourth quarter operating profit of $0.6 million grew by almost 66% compared to the operating profit for the fourth quarter of the prior year. Our gross margin for the fourth quarter was 24.5% and for the full year was 24.3%.

"We continued our strategy of investing in the business of the future during the fourth quarter by spending $1.0 million of general and administrative expenses for research and development and sales and marketing. Including this investment, we held general and administrative expenses flat with the year-ago quarter, demonstrating scalability as we continue to grow the business."

Net Revenue

Net revenue for the quarter was $40.0 million, an increase of $6.4 million over the year-ago quarter. This increase represents a top line growth over the year-ago quarter of 19.2%. Pass-through pharmaceutical purchases for the fourth quarter were $37.6 million. Net revenue growth was primarily attributable to the addition of 31 net new facilities subsequent to the fourth quarter of 2006. Same site revenue also increased during the quarter ended December 31, 2007 as compared to last year's fourth quarter.

Expenses

For the fourth quarter of 2007, operating expenses were $30.2 million, or 75.5% of net revenue, compared to $24.4 million, or 72.8% of net revenue, for the fourth quarter of 2006. Fourth quarter results in 2006 were aided by approximately $0.7 million of insurance reimbursements which reduced operating costs. Excluding these expense reductions, margins remained strong and consistent with 2006 results.

General and administrative expenses were reduced to 20.2% of net revenue for the fourth quarter of 2007 from 24.0% of net revenue for the prior year quarter. General and administrative expenses for the fourth quarter of 2007 were $8.1 million compared to year-ago quarter expenses of $8.0 million. Non-cash stock compensation expense was approximately $0.5 million for the fourth quarter of 2007 compared to $0.3 million for the year-ago period. General and administrative expenses excluding non-cash stock compensation, research and development, and sales and marketing were 16.6% of net revenue compared to 19.7% of net revenue in the same period last year. I-trax considers non-cash stock compensation, research and development, and sales and marketing activities as discretionary investments in the future of our business and monitors these items closely. Such investments were $1.4 million for the quarters ended December 31, 2007 and 2006.

Net Income and EBITDA

Net income for the fourth quarter of 2007 was $0.3 million compared to $1.4 million for the year-ago period, which included $1.3 million from discontinued operations. Net income and EBITDA amounts including non-cash stock compensation for the fourth quarter of 2007 and 2006 are as follows ($ in thousands):

                                   December   December
                                   31, 2007   31, 2006
                                  ---------- ----------
Net income                        $      324 $    1,350
Interest                                 141        132
Taxes                                     91         97
Depreciation and amortization          1,167        804
                                  ---------- ----------
EBITDA                            $    1,723 $    2,383
                                  ========== ==========

Excluding income from discontinued operations of $1.3 million, EBITDA in the fourth quarter increased $0.6 million over 2006 results.

Balance Sheet and Cash Flow

The December 31, 2007 balance sheet includes the effects of the acquisition of ProFitness. The aggregate purchase price of $8.3 million was preliminarily allocated as follows (in thousands):

                                                       Estimated
                                            Amount     Useful Life
                                         ------------- -----------
Fair value of tangible assets acquired
 (includes cash of $574)                 $       2,493         N/A
Liabilities assumed                             (1,700)        N/A
Goodwill                                         4,543         N/A
Customer list                                    2,990    20 years
Other intangibles                                   10      1 year
                                         -------------
                                         $       8,336
                                         =============

Cash and cash equivalents increased during 2007 by $3.5 million. Cash provided by operating activities and financing activities was $1.4 million and $10.5 million, respectively, through December 31, 2007. Financing activities were primarily related to $10.1 million of additional borrowings under our senior credit facility, which provided the cash funding for the acquisition of ProFitness as well as $2.4 million of capital expenditures related mainly to software, technology licenses, and enhancements of systems to improve operational efficiency.

At December 31, 2007, I-trax had cash of $10.1 million and bank debt of $19.1 million, of which $3.9 million is classified as a current liability with the remainder classified as a long-term liability. At December 31, 2006, I-trax had cash of $6.6 million and bank debt of $9.1 million. The Company's current ratio has strengthened to 1.31 at the end of 2007 from 1.12 at December 31, 2006.

Conference Call

I-trax will host a conference call at 4:30 p.m. EST today. During the call, Frank A. Martin, chairman, R. Dixon Thayer, chief executive officer, Dr. Raymond J. Fabius, president and chief medical officer, and Bradley S. Wear, chief financial officer, will discuss the Company's financial and operating results. The telephone number for the conference call is (888) 637-2414. Investors may also listen to the conference call on the I-trax website, www.i-trax.com, by selecting the conference link on the Investor Information page.

Investors may access an encore recording of the conference call for one week by calling (888) 880-7231; the pin number is 022108# / 20080208174794#. The encore recording will be available approximately two hours after the conference call concludes. Investors may also access a recording of this call on the Company's website, www.i-trax.com, where a replay of the webcast will be available for 90 days after the call.

Non-GAAP Financial Measures

The Company makes use of EBITDA which is not a recognized term under generally accepted accounting principles, or "GAAP," and should not be considered as an alternative to net income or net cash used in operating activities, which are GAAP measures. The Company believes EBITDA is a useful performance indicator for measuring the growth of the Company's core operations. The Company reconciles EBITDA to net income below. The Company also makes use of adjusted EBITDA which excludes results of discontinued operations.

About I-trax

I-trax is a leading provider of integrated workplace health and productivity management solutions. Serving more than 160 clients at nearly 300 locations in the United States, I-trax offers on-site health, fitness and wellness centers through its CHD Meridian Healthcare, LLC and ProFitness Health Solutions, LLC subsidiaries that deliver primary care, acute care corporate health, occupational health and pharmacy care management services, as well as fitness and wellness programming and integrated disease management programs. CHD Meridian is focused on making the workplace safe, helping companies achieve employer of choice status, and reducing costs while improving the quality of care received and the productivity of the workforce. Managing employer-sponsored health centers for over 40 years, some of CHD Meridian Healthcare's clients include: BMW, Coushatta Casino Resort, Deutsche Bank, Eastman Chemical, Fieldale Farms, Horizon Blue Cross Blue Shield of New Jersey, Lowe's, Toyota and Unum. For more information, visit www.chdmeridian.com.

Safe Harbor Statement: This press release contains forward-looking statements that are based on current expectations and assumptions, which involve a number of risks and uncertainties. Investors are cautioned that these statements may be affected by certain important factors, and consequently, actual operations and results may differ, possibly materially, from those expressed in such statements. The important factors include, but are not limited to: demand for the Company's products and services and the Company's ability to execute new service contracts; uncertainty of future profitability; general economic conditions; the risk associated with a significant concentration of revenue with a limited number of customers; and the Company's ability to renew and maintain contracts with existing customers under existing terms. I-trax undertakes no obligation to update or revise any forward-looking statement. These and other risks pertaining to I-trax are described in greater detail in I-trax's filings with the Securities and Exchange Commission.

Attached: Balance sheet, statement of operations and reconciliation of a non-GAAP financial measure.

                      I-TRAX, INC. AND SUBSIDIARIES
              CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
                                (Unaudited)
                    (in thousands, except share data)


                              Three Months Ended         Year To Date
                                  December 31             December 31
                                2007       2006        2007        2006
                            =========== ==========  ==========  ==========

Net revenue                 $    39,958 $   33,527  $  143,193  $  124,589

Costs and expenses:
  Operating expenses             30,168     24,397     108,449      93,247
  General and
   administrative expenses        8,067      8,046      29,860      26,401
  Lease termination expense           -          -         780           -
  Depreciation and
   amortization                   1,163        746       4,166       3,259
                            ----------- ----------  ----------  ----------
Total costs and expenses         39,398     33,189     143,255     122,907

Operating profit (loss)             560        338         (62)      1,682

  Interest                          141        132         565         474
  Amortization of financing
   costs                              4         58          77         230
  Other                               -          -      (1,421)          -
                            ----------- ----------  ----------  ----------
Income before provision for
 income taxes                       415        148         717         978

  Provision for income
   taxes                             91         97         519         511
                            ----------- ----------  ----------  ----------

Income from continuing
 operations                         324         51         198         467

Income from discontinued
 operations                           -      1,299           -       1,299
                            ----------- ----------  ----------  ----------

Net income                          324      1,350         198       1,766

Less preferred stock
 dividend                           110        282         577       1,184
                            ----------- ----------  ----------  ----------

Net income (loss)
 applicable to common
 stockholders               $       214 $    1,068  $     (379) $      582
                            =========== ==========  ==========  ==========

Net income (loss) per
 common share, basic:
  From continuing
   operations               $      0.01 $    (0.01) $    (0.01) $    (0.02)
                            =========== ==========  ==========  ==========
  From discontinued
   operations               $         - $     0.04  $        -  $     0.04
                            =========== ==========  ==========  ==========
  Net income (loss) per
   common share             $      0.01 $     0.03  $    (0.01) $     0.02
                            =========== ==========  ==========  ==========

Net income (loss) per
 common share, diluted:
  From continuing
   operations               $      0.00 $    (0.01) $    (0.01) $    (0.02)
                            =========== ==========  ==========  ==========
  From discontinued
   operations               $         - $     0.03  $        -  $     0.03
                            =========== ==========  ==========  ==========
  Net income (loss) per
   common share             $      0.00 $     0.03  $    (0.01) $     0.02
                            =========== ==========  ==========  ==========

Weighted average shares
  Basic                      41,269,808 36,526,863  40,274,272  36,039,650
                            =========== ==========  ==========  ==========
  Diluted                    43,263,842 38,038,940  40,274,272  37,614,510
                            =========== ==========  ==========  ==========

Reconciliation of net
 income to EBITDA

Net income                  $       324 $    1,350  $      198  $    1,766
Add: Depreciation and
 amortization                     1,167        804       4,243       3,489
Add: Provision for income
 taxes                               91         97         519         511
Add: Interest                       141        132         565         474
                            ----------- ----------  ----------  ----------
EBITDA                      $     1,723 $    2,383  $    5,525  $    6,240
                            =========== ==========  ==========  ==========

Recconciliation of EBITDA
 to Adjusted EBITDA
EBITDA                      $     1,723 $    2,383  $    5,525  $    6,240
Less: Income from
 discontinued operations              -     (1,299)          -      (1,299)
Add: Lease termination
 expense                              -          -         780           -
                            ----------- ----------  ----------  ----------
Adjusted EBITDA             $     1,723 $    1,084  $    6,305  $    4,941
                            =========== ==========  ==========  ==========




                      I-TRAX, INC. AND SUBSIDIARIES
                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                (Unaudited)
                    (in thousands, except share data)



                                      December 31, 2007  December 31, 2006
Assets
   Current assets
     Cash and cash equivalents        $          10,075  $           6,558
     Accounts receivable, net                    29,450             21,704
     Other current assets                           943              1,526
                                      -----------------  -----------------
   Total current assets                          40,468             29,788

   Property, plant and equipment, net             4,735              3,377
   Intangible assets, net                        76,296             70,181
   Other assets                                      36                 41

                                      -----------------  -----------------
Total assets                          $         121,535  $         103,387
                                      =================  =================

Liabilities and stockholders' equity

   Current liabilities
     Accounts payable                 $           9,895  $          10,376
     Credit Facility - Current                    3,939                  -
     Accrued purchase price - current               149                  -
     Other accruals and liabilities              16,939             16,189
                                      -----------------  -----------------
   Total current liabilities                     30,922             26,565

   Credit Facility - long term                   15,198              9,057
   Accrued purchase price - long term               750                  -
   Other long term liabilities                    5,660              2,074
                                      -----------------  -----------------
   Total liabilities                             52,530             37,696

   Stockholders' equity
     Preferred Stock                                  0                  1
     Common Stock                                    41                 35
     Paid in capital                            140,496            136,623
     Accumulated deficit                        (71,532)           (70,968)
                                      -----------------  -----------------
   Total stockholders' equity                   69,005             65,691

                                      -----------------  -----------------
Total liabilities and stockholders'
 equity                               $         121,535  $         103,387
                                      =================  =================

Contact Information

  • Company Contact:
    Michele Hart-Henry
    I-trax, Inc.
    (610) 459-2405 x109
    Email Contact

    Public Relations Contact:
    Lindsay Rubin
    Edelman
    (212) 704-8227
    Email Contact

    4 Hillman Drive, Suite 130
    Chadds Ford, PA, 19317
    (610) 459-2405
    www.i-trax.com